Greenwich Lifesciences Inc (GLSI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GLSI Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Greenwich Lifesciences Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent8.88
Cash & Short-term Investments8.00
Total Current Assets8.88
Other Assets, Noncurrent0.00
Total Assets8.88
Liabilities
Accounts Payable and Accrued Liabilities, Current LI5.03
Employee-related Liabilities, Current AC0.22
Other Liabilities, Current0.00
Deferred Compensation Liability, Current LI0.67
Total Current Liabilities5.76
Total Long-term Debt0.00
Deferred Compensation Liability, Current and Noncurrent LI0.00
Other liabilities, Noncurrent0.00
Total Liabilities5.76
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock99.85
Retained Earnings / Accumulated Deficit-96.74
Other Equity0.00
Common Stockholder's Equity3.12
Total Stockholder's Equity3.12
Liabilities & Stockholder's Equity8.88
4 historic quarters locked

Sign in to unlock the full Greenwich Lifesciences Inc balance sheet history.

About Greenwich Lifesciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 11, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-037147

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.